The potential of flavonoids in the treatment of non-alcoholic fatty liver disease

The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) comprises multiple parallel pathways with a dynamic cross talk that cumulate in steatosis and inflammation, and ultimately fibrosis, cirrhosis, liver failure, and hepatocellular carcinoma. So far, no pharmacologic...

Full description

Saved in:
Bibliographic Details
Published in:Critical reviews in food science and nutrition 2017-03, Vol.57 (4), p.834-855
Main Authors: Van De Wier, Bregje, Koek, Ger H., Bast, Aalt, Haenen, Guido R. M. M.
Format: Article
Language:English
Subjects:
Animals
Anti-Inflammatory Agents - chemistry
Anti-Inflammatory Agents - therapeutic use
antioxidants
Flavonoids
Flavonoids - chemistry
Flavonoids - therapeutic use
Humans
Liver diseases
Molecular Structure
NAFLD
Non-alcoholic Fatty Liver Disease - drug therapy
Non-alcoholic Fatty Liver Disease - etiology
non-alcoholic steatohepatitis
Oxidative stress
Plants, Medicinal - chemistry
polyphenols
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) comprises multiple parallel pathways with a dynamic cross talk that cumulate in steatosis and inflammation, and ultimately fibrosis, cirrhosis, liver failure, and hepatocellular carcinoma. So far, no pharmacological treatment has been approved. A major impediment of drugs, in general, is that they are intended to act on one single target in the pathology of a disease. However, the multitude of pathways involved in the pathogenesis of NAFLD underpins the need for treatments that address these various pathways. Interestingly, flavonoids have been found to have positive effects on lipid metabolism, insulin resistance, inflammation, and oxidative stress, the most important pathophysiological pathways in NAFLD. This puts flavonoids in the spotlight for the treatment of NAFLD and prompted us to review the existing evidence for the use of these food-derived compounds in the treatment of NAFLD.
ISSN:1040-8398
1549-7852
DOI:10.1080/10408398.2014.952399